Cancer Patients’ Perspectives and Experiences of Chemotherapy-Induced Myelosuppression and Its Impact on Daily Life
Robert S Epstein,1 Upal K Basu Roy,2 Matti Aapro,3 Tehseen Salimi,4 Donald Moran,4 JoAnn Krenitsky,1 Megan L Leone-Perkins,5 Cynthia Girman,6 Courtney Schlusser,7 Jeffrey Crawford8 1Epstein Health, LLC., Woodcliff Lake, NJ, USA; 2LUNGevity Foundation, Bethesda, MD, USA; 3Clinique De Genolier, Genoli...
Main Authors: | Epstein RS, Basu Roy UK, Aapro M, Salimi T, Moran D, Krenitsky J, Leone-Perkins ML, Girman C, Schlusser C, Crawford J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-02-01
|
Series: | Patient Preference and Adherence |
Subjects: | |
Online Access: | https://www.dovepress.com/cancer-patientsrsquo-perspectives-and-experiences-of-chemotherapy-indu-peer-reviewed-article-PPA |
Similar Items
-
Promotion of myelopoiesis in myelosuppressed mice by Ganoderma lucidum polysaccharides
by: Xiao Ling Zhu, et al.
Published: (2012-02-01) -
H2S protects against fatal myelosuppression by promoting the generation of megakaryocytes/platelets
by: Huan-Di Liu, et al.
Published: (2016-02-01) -
Alopecia as the first manifestation of azathioprine myelosuppression in a genetically predisposed patient
by: Debashish Mishra, et al.
Published: (2019-01-01) -
The mechanisms of blood system regulation under myelosuppressive influences
by: E. D. Goldberg, et al.
Published: (2002-06-01) -
Complications of MRSA Treatment: Linezolid-induced Myelosuppression Presenting with Pancytopenia
by: Gorchynski, Julie A, et al.
Published: (2008-08-01)